Acquisitions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions |
1 Months Ended | ||
|---|---|---|---|
Mar. 04, 2026 |
Jul. 25, 2025 |
Mar. 31, 2026 |
|
| Ventyx Biosciences, Inc | |||
| Business Combination [Line Items] | |||
| Cash | $ 120 | ||
| Acquired in-process research and development (IPR&D) | 977 | ||
| Other assets and liabilities, net | 81 | ||
| Acquisition date fair value of consideration transferred | 1,178 | ||
| Less: | |||
| Cash acquired | (120) | ||
| Cash paid, net of cash acquired | $ 1,058 | $ 1,100 | |
| Verve Therapeutics, Inc. | |||
| Business Combination [Line Items] | |||
| Cash | $ 389 | ||
| Acquired in-process research and development (IPR&D) | 608 | ||
| Other assets and liabilities, net | 166 | ||
| Acquisition date fair value of consideration transferred | 1,163 | ||
| Less: | |||
| Cash acquired | (389) | ||
| Fair value of CVR liability | (177) | ||
| Fair value of equity interest in Verve held before the business combination | (48) | ||
| Cash paid, net of cash acquired | $ 549 |
| X | ||||||||||
- Definition Business Combination, Cash Acquired No definition available.
|
| X | ||||||||||
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in excess of (less than) liability assumed plus goodwill in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value at acquisition date of equity interest in acquiree held by acquirer immediately before acquisition date in business combination achieved in stages. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|